» Authors » Kensei Nakata

Kensei Nakata

Explore the profile of Kensei Nakata including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 311
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Onishi H, Shioyama Y, Matsumoto Y, Matsuo Y, Miyakawa A, Yamashita H, et al.
Cancers (Basel) . 2023 Sep; 15(17). PMID: 37686657
Surgery is the standard treatment for stage I non-small cell lung cancer (NSCLC); however, no clear randomized trial demonstrates its superiority to stereotactic body radiotherapy (SBRT) regarding survival. We aimed...
2.
Inada M, Nishimura Y, Ishikura S, Ishikawa K, Murakami N, Kodaira T, et al.
Radiat Oncol . 2022 Jul; 17(1):133. PMID: 35902868
Background: JCOG1015A1 is an ancillary research study to determine the organ-specific dose constraints in head and neck carcinoma treated with intensity-modulated radiation therapy (IMRT) using data from JCOG1015. Methods: Individual...
3.
Nishimura Y, Ishikura S, Shibata T, Kodaira T, Ito Y, Tsuchiya K, et al.
Int J Clin Oncol . 2020 Mar; 25(7):1250-1259. PMID: 32221802
Background: A phase II study of adaptive two-step intensity-modulated radiotherapy (IMRT) with chemotherapy for nasopharyngeal cancer (NPC) (JCOG1015) was conducted to evaluate the efficacy and safety. Methods: Patients aged 20-75 ...
4.
Someya M, Hasegawa T, Tsuchiya T, Kitagawa M, Gocho T, Fukushima Y, et al.
J Radiat Res . 2020 Feb; 61(2):265-274. PMID: 32009177
Combining external beam radiotherapy (EBRT) with intracavitary brachytherapy (ICBT) is important for definitive treatment of cervical cancer. In cervical cancer patients receiving radiotherapy, we evaluated treatment outcomes in relation to...
5.
Tsuchiya T, Someya M, Takada Y, Hasegawa T, Kitagawa M, Fukushima Y, et al.
Strahlenther Onkol . 2020 Jan; 196(8):725-735. PMID: 31953603
Purpose: To evaluate radiotherapy-induced changes in the expression of programmed death ligand 1 (PD-L1), programmed death 1 (PD-1), and human leukocyte antigen class I (HLA-1) in patients with uterine cervical...
6.
Kato J, Hida T, Someya M, Sato S, Sawada M, Horimoto K, et al.
J Dermatol . 2019 Feb; 46(4):328-333. PMID: 30758859
Some studies showed that clinical response to immune check point inhibitors is lower in acral and mucosal melanoma than in cutaneous melanoma. Although the synergistic effect of radiotherapy (RT) and...
7.
Fukushima Y, Someya M, Nakata K, Hori M, Kitagawa M, Hasegawa T, et al.
Radiother Oncol . 2018 Sep; 129(2):409-414. PMID: 30249348
Background And Purpose: To investigate influences of proteins involved with tumor immunity on outcomes of radiotherapy for oropharyngeal squamous cell carcinoma (OPSCC). Material And Methods: We performed immunohistochemical staining to...
8.
Onishi H, Yamashita H, Shioyama Y, Matsumoto Y, Takayama K, Matsuo Y, et al.
Cancers (Basel) . 2018 Aug; 10(8). PMID: 30072613
Pretreatment pulmonary interstitial change (PIC) has been indicated as a risk factor of severe radiation pneumonitis (RP) following stereotactic body radiation therapy (SBRT) for early-stage lung cancer, but details of...
9.
Someya M, Hori M, Gocho T, Nakata K, Tsuchiya T, Kitagawa M, et al.
Jpn J Clin Oncol . 2017 Dec; 48(2):167-174. PMID: 29281088
Background: To search for novel biomarkers that can predict acute radiation toxicity, we conducted microRNA expression analysis of peripheral blood lymphocytes (PBLs). Methods: The discovery cohort was 69 patients with...
10.
Someya M, Hasegawa T, Hori M, Matsumoto Y, Nakata K, Masumori N, et al.
J Radiat Res . 2017 Apr; 58(2):225-231. PMID: 28399576
Repair of DNA damage is critical for genomic stability, and DNA-dependent protein kinase (DNA-PK) has an important role in repairing double-strand breaks. We examined whether the DNA-PK activity of peripheral...